| 发明名称 |
Treatment of dyskinesia |
| 摘要 |
The present invention relates to the use of compounds that enhance H<SUB>3</SUB>-histamine receptor activity, or activation (e.g. H<SUB>3</SUB>-histamine receptor agonists) for the treatment of dyskinesia. The compounds are particularly useful for treating dyskinesia associated with parkinsonian therapy.
|
| 申请公布号 |
US2005245587(A1) |
申请公布日期 |
2005.11.03 |
| 申请号 |
US20040974980 |
申请日期 |
2004.10.28 |
| 申请人 |
MOTAC NEUROSCIENCE LIMITED |
发明人 |
BROTCHIE JONATHAN;HILL MICHAEL;CROSSMAN ALAN |
| 分类号 |
A61K45/00;A61K31/00;A61K31/155;A61K31/198;A61K31/4164;A61K31/417;A61K31/435;A61K31/454;A61K31/473;A61K31/55;A61K48/00;A61P25/14;A61P25/16;A61P43/00;(IPC1-7):A61K31/417 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
